<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">GE Port J Gastroenterol</journal-id><journal-id journal-id-type="iso-abbrev">GE Port J Gastroenterol</journal-id><journal-title-group><journal-title>GE Portuguese Journal of Gastroenterology</journal-title></journal-title-group><issn pub-type="ppub">2341-4545</issn><issn pub-type="epub">2387-1954</issn><publisher><publisher-name>Karger Publishers</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28868453</article-id><article-id pub-id-type="pmc">5580138</article-id><article-id pub-id-type="publisher-id">S2341-4545(15)00137-4</article-id><article-id pub-id-type="doi">10.1016/j.jpge.2015.10.004</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Case</subject></subj-group></article-categories><title-group><article-title>Visceral Angioedema Induced by Angiotensin Converting Enzyme Inhibitor: Case Report</article-title><trans-title-group xml:lang="pt"><trans-title>Angioedema Visceral Induzido por Inibidor da Enzima de Convers&#x000e3;o da Angiotensina: Caso Cl&#x000ed;nico</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name><surname>Frutuoso</surname><given-names>Beatriz</given-names></name><email>beatriz.frutuoso@chvng.min-saude.pt</email><xref rid="aff0005" ref-type="aff">a</xref><xref rid="cor0005" ref-type="corresp">&#x0204e;</xref></contrib><contrib contrib-type="author"><name><surname>Esteves</surname><given-names>Joana</given-names></name><xref rid="aff0010" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Silva</surname><given-names>Mafalda</given-names></name><xref rid="aff0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Gil</surname><given-names>Pedro</given-names></name><xref rid="aff0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Carneiro</surname><given-names>Ana Cristina</given-names></name><xref rid="aff0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Vale</surname><given-names>S&#x000ed;lvio</given-names></name><xref rid="aff0010" ref-type="aff">b</xref></contrib></contrib-group><aff id="aff0005"><label>a</label>Internal Medicine Department, Centro Hospitalar Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal</aff><aff id="aff0010"><label>b</label>General Surgery Department, Centro Hospitalar Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal</aff><author-notes><corresp id="cor0005"><label>&#x0204e;</label>Corresponding author. <email>beatriz.frutuoso@chvng.min-saude.pt</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>02</day><month>12</month><year>2015</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="collection"><season>May-Jun</season><year>2016</year></pub-date><pub-date pub-type="epub"><day>02</day><month>12</month><year>2015</year></pub-date><volume>23</volume><issue>3</issue><fpage>166</fpage><lpage>169</lpage><history><date date-type="received"><day>8</day><month>8</month><year>2015</year></date><date date-type="accepted"><day>6</day><month>10</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; 2015 Sociedade Portuguesa de Gastrenterologia. Published by Elsevier Espa&#x000f1;a, S.L.U.</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Sociedade Portuguesa de Gastrenterologia</copyright-holder><license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/"><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p></license></permissions><abstract id="abs0010"><sec><title>Introduction</title><p>Intestinal angioedema is a rare adverse effect of angiotensin converting enzyme inhibitors.</p></sec><sec><title>Clinical case</title><p>A 42-year old woman presented to the Emergency Department complaining of diffuse abdominal pain, predominantly in the right quadrants, with no other associated symptoms.</p><p>She had been started on perindopril plus indapamide 72&#x000a0;h before the admission for arterial hypertension. There was no other relevant background.</p><p>Physical examination suggested peritoneal irritation on the lower quadrants of the abdomen and right flank.</p><p>Laboratory tests were relevant for mild leukocytosis. Abdomen ultrasound and contrast-enhanced computed tomography scan showed moderate amount of fluid in the pelvic excavation and small intestine wall thickening. She was admitted for observation. Once the hypothesis of intestinal angioedema was admitted, angiotensin converting enzyme inhibitor was withheld and no other-directed therapy was instituted. Within 24&#x000a0;h she showed clinical, analytic and imaging improvement, thus supporting this diagnosis.</p></sec><sec><title>Conclusion</title><p>The diagnosis of intestinal angioedema induced by angiotensin converting enzyme inhibitor can be challenging and time consuming due to its rarity and nonspecific symptoms, which may lead to underdiagnosis of this entity.</p></sec></abstract><trans-abstract xml:lang="pt"><title>Resumo</title><sec><title>Introdu&#x000e7;&#x000e3;o</title><p>O angioedema intestinal &#x000e9; um efeito adverso raro dos inibidores da enzima de convers&#x000e3;o da angiotensina.</p></sec><sec><title>Caso cl&#x000ed;nico</title><p>Sexo feminino, 42 anos, recorreu ao Servi&#x000e7;o de Urg&#x000ea;ncia por dor abdominal difusa predominante nos quadrantes direitos, sem outra sintomatologia. Tinha iniciado perindopril e indapamida 72&#x000a0;horas antes por hipertens&#x000e3;o arterial. Sem outros antecedentes de relevo. Ao exame objetivo salientava-se apenas sinais de irrita&#x000e7;&#x000e3;o peritoneal &#x000e0; palpa&#x000e7;&#x000e3;o da fossa il&#x000ed;aca e flanco direitos. Analiticamente evidenciava discreta leucocitose, sem outras altera&#x000e7;&#x000f5;es. A ecografia e tomografia computorizada contrastada abdominal revelaram l&#x000ed;quido moderado na escava&#x000e7;&#x000e3;o p&#x000e9;lvica e espessamento das paredes do delgado. Foi internada para vigil&#x000e2;ncia. Admitindo-se angioedema intestinal, o inibidor da enzima de convers&#x000e3;o da angiotensina foi suspenso e n&#x000e3;o foi institu&#x000ed;da qualquer outra terap&#x000ea;utica dirigida. Em 24&#x000a0;horas, verificou-se melhoria cl&#x000ed;nica, anal&#x000ed;tica e imagiol&#x000f3;gica, corroborando a hip&#x000f3;tese de diagn&#x000f3;stico.</p></sec><sec><title>Conclus&#x000e3;o</title><p>O diagn&#x000f3;stico de angioedema intestinal por inibidor da enzima de convers&#x000e3;o da angiotensina &#x000e9;, por vezes, dif&#x000ed;cil e moroso pela sua raridade e inespecificidade dos sintomas, podendo conduzir ao subdiagn&#x000f3;stico desta entidade.</p></sec></trans-abstract><kwd-group id="kwd0005"><title>Keywords</title><kwd>Angioedema</kwd><kwd>Angiotensin-Converting Enzyme Inhibitors/adverse effects</kwd><kwd>Intestinal Diseases</kwd></kwd-group><kwd-group xml:lang="pt" id="kwd0010"><title>Palavras-chave</title><kwd>Angioedema</kwd><kwd>Inibidor da Enzima de Convers&#x000e3;o da Angiotensina/efeitos adversos</kwd><kwd>Doen&#x000e7;as Intestinais</kwd></kwd-group></article-meta></front><body><sec id="sec0005"><label>1</label><title>Introduction</title><p>Angiotensin converting enzyme (ACE) inhibitors are widely used in clinical practice. Angioedema is a rare adverse reaction, occurring in approximately 0.1&#x02013;0.7% of patients.<xref rid="bib0115" ref-type="bibr"><sup>1</sup></xref> Although the risk to an individual is relatively low, the large number of people taking these medications, calculated in more than 40 million patients in the United States, means the absolute number of ACE inhibitor induced angioedema is, in fact, significant.<xref rid="bib0115" ref-type="bibr"><sup>1</sup></xref> Most of the cases described in literature refer to angioedema of the lips, tongue, face, or airway.<xref rid="bib0115" ref-type="bibr"><sup>1</sup></xref> More rarely, visceral involvement may occur, especially in the jejunum.<xref rid="bib0115" ref-type="bibr">1</xref>, <xref rid="bib0120" ref-type="bibr">2</xref>, <xref rid="bib0125" ref-type="bibr">3</xref> The exact incidence of visceral angioedema induced by ACE inhibitor is unknown and this condition is probably underdiagnosed.<xref rid="bib0115" ref-type="bibr">1</xref>, <xref rid="bib0130" ref-type="bibr">4</xref>, <xref rid="bib0135" ref-type="bibr">5</xref>, <xref rid="bib0140" ref-type="bibr">6</xref>, <xref rid="bib0145" ref-type="bibr">7</xref> In a literature review from 1980 to 2010, Korniyenko et al reported 27 published cases.<xref rid="bib0125" ref-type="bibr"><sup>3</sup></xref></p><p>The authors present a case of intestinal angioedema induced by ACE inhibitor.</p></sec><sec id="sec0010"><label>2</label><title>Clinical case</title><p>A 42-year old caucasian woman presented to the Emergency Department complaining of diffuse abdominal pain, predominantly in the right quadrants, for the last 10&#x000a0;h. She was previously asymptomatic and, at admission, did not have any other symptoms, including nausea, vomiting, diarrhea or any other gastrointestinal symptom, breathing difficulty, cough, rash or pruritus.</p><p>She had been started on perindopril plus indapamide 72&#x000a0;h before the admission for arterial hypertension, with no other relevant background.</p><p>At admission, significant findings on physical exam included an arterial pressure of 112/72&#x000a0;mmHg, pulse of 61 per minute, peripheral oxygen saturation of 100% on room air and tympanic temperature of 37&#x000a0;&#x000b0;C. There was no swelling of the face, oral cavity or tongue, dyspnea or stridor. Abdominal examination showed signs of peritoneal irritation on lower quadrants of the abdomen and right flank.</p><p>Laboratory tests were relevant for mild leukocytosis with high neutrophil count (12.910&#x000a0;leukocyte/&#x003bc;L, 79.2% of neutrophil). The remaining analysis, including liver enzymes were within the normal range &#x02013; aminotransferase aspartate: 22&#x000a0;U/L, aminotransferase alanine: 22&#x000a0;U/L (normal 4&#x02013;33/4&#x02013;50, respectively), pancreatic amylase: 28&#x000a0;U/L (normal 13&#x02013;53), lipase: 24&#x000a0;U/L (normal 13&#x02013;60) or C-reactive protein: 0.35&#x000a0;mg/dL (normal &#x0003c;0.5). Abdominal ultrasound revealed thickening of intestinal wall associated with abdominal fluid. A contrast-enhanced abdominal computed tomography (CT) was done for further characterization (<xref rid="fig0005" ref-type="fig">Fig. 1</xref>), showing a moderate amount of liquid in the pelvic excavation and wall thickening of small intestine, cecum and ascending colon.<fig id="fig0005"><label>Figure 1</label><caption><p>Contrast-enhanced computed tomography demonstrating circumferential transmural thickening of ileum walls, producing a target-like lesion (arrows) that is typical of edema.</p></caption><graphic xlink:href="gr1"/></fig></p><p>She was admitted for observation. Once the hypothesis of intestinal angioedema was admitted, ACE inhibitor was withheld. The patient was started on intravenous fluids and analgesics and kept on nothing by mouth status. Within 24&#x000a0;h she showed clinical, analytic and imaging improvement, with ultrasound still revealing moderate free fluid, but less expressive wall thickening of the small intestine loops.</p><p>The clear improvement in 24&#x000a0;h without other treatment besides perindopril withholding, in the scenario of no symptoms or history suggestive of any alternative diagnosis strongly supported ACE inhibitor induced angioedema.</p><p>The patient was discharged home, advised not to resume any ACE inhibitors. One year later she remained asymptomatic.</p></sec><sec id="sec0015"><label>3</label><title>Discussion</title><p>Visceral angioedema induced by ACE inhibitor is a rare, but well-established entity, described in some publications.<xref rid="bib0125" ref-type="bibr"><sup>3</sup></xref></p><p>Studies suggest that elevated levels of bradykinin, a vasodilator peptide degraded by angiotensin converting enzyme, result in vasodilation and increased vascular permeability causing the edema.<xref rid="bib0115" ref-type="bibr">1</xref>, <xref rid="bib0125" ref-type="bibr">3</xref>, <xref rid="bib0130" ref-type="bibr">4</xref>, <xref rid="bib0150" ref-type="bibr">8</xref>, <xref rid="bib0155" ref-type="bibr">9</xref></p><p>Female sex appears to have a major predisposition to it and its incidence is five times greater in black people.<xref rid="bib0115" ref-type="bibr">1</xref>, <xref rid="bib0130" ref-type="bibr">4</xref>, <xref rid="bib0160" ref-type="bibr">10</xref></p><p>Jejunum is most often affected followed by ileum and duodenum.<xref rid="bib0115" ref-type="bibr">1</xref>, <xref rid="bib0120" ref-type="bibr">2</xref>, <xref rid="bib0125" ref-type="bibr">3</xref> There are reports of gastric involvement.<xref rid="bib0125" ref-type="bibr">3</xref>, <xref rid="bib0165" ref-type="bibr">11</xref></p><p>ACE inhibitor induced angioedema is characterized by the absence of pruriginous rash.<xref rid="bib0115" ref-type="bibr">1</xref>, <xref rid="bib0135" ref-type="bibr">5</xref></p><p>It presents as diffuse abdominal pain, diarrhea, vomiting and anorexia.<xref rid="bib0115" ref-type="bibr">1</xref>, <xref rid="bib0120" ref-type="bibr">2</xref>, <xref rid="bib0125" ref-type="bibr">3</xref>, <xref rid="bib0170" ref-type="bibr">12</xref> Symptoms usually begin 72&#x000a0;h after starting ACE inhibitor,<xref rid="bib0150" ref-type="bibr">8</xref>, <xref rid="bib0175" ref-type="bibr">13</xref>, <xref rid="bib0180" ref-type="bibr">14</xref>, <xref rid="bib0185" ref-type="bibr">15</xref> but there are reports of angioedema that developed after weeks<xref rid="bib0160" ref-type="bibr">10</xref>, <xref rid="bib0190" ref-type="bibr">16</xref> or years of therapy.<xref rid="bib0120" ref-type="bibr">2</xref>, <xref rid="bib0160" ref-type="bibr">10</xref>, <xref rid="bib0195" ref-type="bibr">17</xref>, <xref rid="bib0200" ref-type="bibr">18</xref> Typically symptoms resolve 48&#x000a0;h after ACE inhibitor suspension.<xref rid="bib0125" ref-type="bibr">3</xref>, <xref rid="bib0130" ref-type="bibr">4</xref></p><p>The laboratory evaluation is often normal or it may exhibit mild leukocytosis.<xref rid="bib0120" ref-type="bibr">2</xref>, <xref rid="bib0125" ref-type="bibr">3</xref></p><p>Radiologic studies show small intestine wall thickening, mesenteric edema and ascites<xref rid="bib0120" ref-type="bibr">2</xref>, <xref rid="bib0125" ref-type="bibr">3</xref>, <xref rid="bib0145" ref-type="bibr">7</xref>, <xref rid="bib0160" ref-type="bibr">10</xref>, <xref rid="bib0175" ref-type="bibr">13</xref>, <xref rid="bib0205" ref-type="bibr">19</xref>, <xref rid="bib0210" ref-type="bibr">20</xref>, <xref rid="bib0215" ref-type="bibr">21</xref>, <xref rid="bib0220" ref-type="bibr">22</xref> that may simulate ischemia or inflammatory bowel disease.<xref rid="bib0120" ref-type="bibr">2</xref>, <xref rid="bib0130" ref-type="bibr">4</xref>, <xref rid="bib0205" ref-type="bibr">19</xref>, <xref rid="bib0215" ref-type="bibr">21</xref>, <xref rid="bib0220" ref-type="bibr">22</xref> Typically, there are target-like images on contrast-enhanced radiologic studies specific of intestinal wall edema, no matter the cause of the edema.<xref rid="bib0120" ref-type="bibr">2</xref>, <xref rid="bib0125" ref-type="bibr">3</xref>, <xref rid="bib0205" ref-type="bibr">19</xref>, <xref rid="bib0220" ref-type="bibr">22</xref></p><p>Oudit et al,<xref rid="bib0130" ref-type="bibr"><sup>4</sup></xref> proposed four diagnostic criteria based on the use of ACE inhibitor (regardless of dose and duration of use), nonspecific abdominal complaints in the presence of visceral edema (with or without ascites), resolution of symptoms and radiological changes following discontinuation of ACE inhibitor and lack of alternative diagnoses.</p><p>In this report, opposite to other publications, the only complain was abdominal pain, with no additional gastrointestinal symptoms. However, presentation within 72&#x000a0;h after starting perindopril, unspecific laboratory findings, as well as characteristic imaging were suggestive and facilitated the diagnosis of ACE inhibitor angioedema. Furthermore, as there is not a single, definitive diagnostic test it is crucial to rule out other possible diagnoses. In this case, the clinical history and complementary methods of diagnosis allowed the exclusion of acute hepatitis or pancreatitis, mesenteric ischemia, intestinal obstruction, appendicitis, acute cholecystitis or lymphoproliferative disease. Acute gastroenteritis was very unlikely, given the lack of other symptoms beyond abdominal pain. There was no personal or family history that led into the hypothesis of hereditary C1 esterase inhibitor deficiency, vasculitis or inflammatory bowel disease. Global improvement after suspension of the drug, with no other-directed therapy, supported this hypothesis.</p></sec><sec id="sec0020"><label>4</label><title>Conclusion</title><p>Visceral angioedema is a rare, but well-described adverse effect of ACE inhibitor therapy. The diagnosis is often challenging and time consuming, requiring careful evaluation of the patient's medication and their side effects.</p></sec><sec id="sec0025"><title>Ethical disclosures</title><sec id="sec0030"><title>Protection of human and animal subjects</title><p>The authors declare that no experiments were performed on humans or animals for this study.</p></sec><sec id="sec0035"><title>Confidentiality of data</title><p>The authors declare that they have followed the protocols of their work center on the publication of patient data</p></sec><sec id="sec0040"><title>Right to privacy and informed consent</title><p>The authors have obtained the written informed consent of the patients or subjects mentioned in the article. The corresponding author is in possession of this document.</p></sec></sec><sec id="sec0045"><title>Funding</title><p>The author(s) received no financial support for the research and/or authorship of this article.</p></sec><sec id="sec0050"><title>Conflicts of interest</title><p>The authors declared no conflict of interest with respect to the authorship and/or publication of this article.</p></sec></body><back><ref-list id="bibl0005"><title>References</title><ref id="bib0115"><label>1</label><element-citation publication-type="journal" id="sbref0115"><person-group person-group-type="author"><name><surname>Guyer</surname><given-names>A.C.</given-names></name><name><surname>Banerji</surname><given-names>A.</given-names></name></person-group><article-title>ACE inhibitor-induced angioedema</article-title><source>UpToDate</source><year>2015</year></element-citation></ref><ref id="bib0120"><label>2</label><element-citation publication-type="journal" id="sbref0120"><person-group person-group-type="author"><name><surname>Scheirey</surname><given-names>C.D.</given-names></name><name><surname>Scholz</surname><given-names>F.J.</given-names></name><name><surname>Shortsleeve</surname><given-names>M.J.</given-names></name><name><surname>Katz</surname><given-names>D.S.</given-names></name></person-group><article-title>Angiotensin-converting enzyme inhibitor-induced small-bowel angioedema: clinical and imaging findings in 20 patients</article-title><source>Am J Roentgenol</source><volume>197</volume><year>2011</year><fpage>393</fpage><lpage>398</lpage><pub-id pub-id-type="pmid">21785085</pub-id></element-citation></ref><ref id="bib0125"><label>3</label><element-citation publication-type="journal" id="sbref0125"><person-group person-group-type="author"><name><surname>Korniyenko</surname><given-names>A.</given-names></name><name><surname>Alviar</surname><given-names>C.L.</given-names></name><name><surname>Cordova</surname><given-names>J.P.</given-names></name><name><surname>Messerli</surname><given-names>F.H.</given-names></name></person-group><article-title>Visceral angioedema due to angiotensin-converting enzyme inhibitor therapy</article-title><source>Clevel Clin J Med</source><volume>78</volume><year>2011</year><fpage>297</fpage><lpage>304</lpage></element-citation></ref><ref id="bib0130"><label>4</label><element-citation publication-type="journal" id="sbref0130"><person-group person-group-type="author"><name><surname>Oudit</surname><given-names>G.</given-names></name><name><surname>Girgrah</surname><given-names>N.</given-names></name><name><surname>Allard</surname><given-names>J.</given-names></name></person-group><article-title>ACE inhibitor-induced angioedema of the intestine: case report, incidence, pathophysiology, diagnosis and management</article-title><source>Can J Gastroenterol</source><volume>15</volume><year>2001</year><fpage>827</fpage><lpage>832</lpage><pub-id pub-id-type="pmid">11773949</pub-id></element-citation></ref><ref id="bib0135"><label>5</label><element-citation publication-type="journal" id="sbref0135"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>T.</given-names></name><name><surname>Peckler</surname><given-names>B.</given-names></name><name><surname>Hackstadt</surname><given-names>R.D.</given-names></name><name><surname>Payor</surname><given-names>A.</given-names></name></person-group><article-title>ACE inhibitor-induced angioedema of the bowel</article-title><source>Case Rep Med</source><volume>2010</volume><year>2010</year><fpage>690</fpage><lpage>695</lpage></element-citation></ref><ref id="bib0140"><label>6</label><element-citation publication-type="journal" id="sbref0140"><person-group person-group-type="author"><name><surname>Augenstein</surname><given-names>V.A.</given-names></name><name><surname>Heniford</surname><given-names>B.T.</given-names></name><name><surname>Sing</surname><given-names>R.F.</given-names></name></person-group><article-title>Intestinal angioedema induced by angiotensin-converting enzyme inhibitors: an underrecognized cause of abdominal pain?</article-title><source>J Am Osteopat Assoc</source><volume>113</volume><year>2013</year><fpage>221</fpage><lpage>223</lpage></element-citation></ref><ref id="bib0145"><label>7</label><element-citation publication-type="journal" id="sbref0145"><person-group person-group-type="author"><name><surname>Marmery</surname><given-names>H.</given-names></name><name><surname>Mirvis</surname><given-names>S.E.</given-names></name></person-group><article-title>Angiotensin-converting enzyme inhibitor-induced visceral angioedema</article-title><source>Clin Radiol</source><volume>61</volume><year>2006</year><fpage>979</fpage><lpage>982</lpage><pub-id pub-id-type="pmid">17018312</pub-id></element-citation></ref><ref id="bib0150"><label>8</label><element-citation publication-type="journal" id="sbref0150"><person-group person-group-type="author"><name><surname>De Graaf</surname><given-names>L.C.</given-names></name><name><surname>vans Essen</surname><given-names>M.</given-names></name><name><surname>Schipper</surname><given-names>E.M.</given-names></name><name><surname>Boom</surname><given-names>H.</given-names></name><name><surname>Duschek</surname><given-names>E.J.</given-names></name></person-group><article-title>Unnecessary surgery for acute abdomen secondary to angiotensin-converting enzyme inhibitor to angiotensin-converting enzyme inhibitor use</article-title><source>Am J Emerg Med</source><volume>30</volume><year>2012</year><fpage>1607</fpage><lpage>1612</lpage><pub-id pub-id-type="pmid">22867837</pub-id></element-citation></ref><ref id="bib0155"><label>9</label><element-citation publication-type="journal" id="sbref0155"><person-group person-group-type="author"><name><surname>Thalanayar</surname><given-names>P.M.</given-names></name><name><surname>Ghobrial</surname><given-names>I.</given-names></name><name><surname>Lubin</surname><given-names>F.</given-names></name><name><surname>Karnik</surname><given-names>R.</given-names></name><name><surname>Bhasin</surname><given-names>R.</given-names></name></person-group><article-title>Drug-induced visceral angioedema</article-title><source>J Commun Hosp Intern Med Perspect</source><volume>4</volume><year>2014</year><fpage>25260</fpage></element-citation></ref><ref id="bib0160"><label>10</label><element-citation publication-type="journal" id="sbref0160"><person-group person-group-type="author"><name><surname>Benson</surname><given-names>B.C.</given-names></name><name><surname>Smith</surname><given-names>C.</given-names></name><name><surname>Laczek</surname><given-names>J.T.</given-names></name></person-group><article-title>Angiotensin converting enzyme inhibitor-induced gastrointestinal angioedema: a case series and literature review</article-title><source>J Clin Gastroenterol</source><volume>47</volume><year>2013</year><fpage>844</fpage><lpage>849</lpage><pub-id pub-id-type="pmid">23751839</pub-id></element-citation></ref><ref id="bib0165"><label>11</label><element-citation publication-type="journal" id="sbref0165"><person-group person-group-type="author"><name><surname>Shahzad</surname><given-names>G.</given-names></name><name><surname>Korsten</surname><given-names>M.A.</given-names></name><name><surname>Blatt</surname><given-names>C.</given-names></name><name><surname>Motwani</surname><given-names>P.</given-names></name></person-group><article-title>Angiotensin-converting enzyme (ACE) inhibitor-associated angioedema of the stomach and small intestine: a case report</article-title><source>Mt Sinai J Med</source><volume>73</volume><year>2006</year><fpage>1123</fpage><lpage>1125</lpage><pub-id pub-id-type="pmid">17285209</pub-id></element-citation></ref><ref id="bib0170"><label>12</label><element-citation publication-type="journal" id="sbref0170"><person-group person-group-type="author"><name><surname>Chase</surname><given-names>M.P.</given-names></name><name><surname>Fiarman</surname><given-names>G.S.</given-names></name><name><surname>Scholz</surname><given-names>F.J.</given-names></name><name><surname>MacDermott</surname><given-names>R.P.</given-names></name></person-group><article-title>Angioedema of the small bowel due to an angiotensin-converting enzyme inhibitor</article-title><source>J Clin Gastroenterol</source><volume>31</volume><year>2000</year><fpage>254</fpage><lpage>257</lpage><pub-id pub-id-type="pmid">11034011</pub-id></element-citation></ref><ref id="bib0175"><label>13</label><element-citation publication-type="journal" id="sbref0175"><person-group person-group-type="author"><name><surname>Gon&#x000e7;alves</surname><given-names>B.M.</given-names></name><name><surname>Caetano</surname><given-names>A.C.</given-names></name><name><surname>Ferreira</surname><given-names>A.</given-names></name></person-group><article-title>A rare cause of abdominal pain</article-title><source>Gastroenterology</source><volume>145</volume><year>2013</year><fpage>e11</fpage><lpage>e12</lpage></element-citation></ref><ref id="bib0180"><label>14</label><element-citation publication-type="journal" id="sbref0180"><person-group person-group-type="author"><name><surname>Shahani</surname><given-names>L.</given-names></name></person-group><article-title>ACE inhibitor-induced intestinal angio-oedema: rare adverse effect of a common drug</article-title><source>BMJ Case Rep</source><volume>2013</volume><year>2013</year><comment>pii:bcr2013200171</comment></element-citation></ref><ref id="bib0185"><label>15</label><element-citation publication-type="journal" id="sbref0185"><person-group person-group-type="author"><name><surname>Byrne</surname><given-names>T.J.</given-names></name><name><surname>Douglas</surname><given-names>D.D.</given-names></name><name><surname>Landis</surname><given-names>M.E.</given-names></name><name><surname>Heppell</surname><given-names>J.P.</given-names></name></person-group><article-title>Isolated visceral angioedema: an underdiagnosed complication of ACE inhibitors?</article-title><source>Mayo Clin Proc</source><volume>75</volume><year>2000</year><fpage>1201</fpage><lpage>1204</lpage><pub-id pub-id-type="pmid">11075752</pub-id></element-citation></ref><ref id="bib0190"><label>16</label><element-citation publication-type="journal" id="sbref0190"><person-group person-group-type="author"><name><surname>Spahn</surname><given-names>T.W.</given-names></name><name><surname>Grosse-Thie</surname><given-names>W.</given-names></name><name><surname>Mueller</surname><given-names>M.K.</given-names></name></person-group><article-title>Endoscopic visualization of angiotensin-converting enzyme inhibitor-induced small bowel angioedema as a cause of relapsing abdominal pain using double-balloon enteroscopy</article-title><source>Dig Dis Sci</source><volume>53</volume><year>2008</year><fpage>1257</fpage><lpage>1260</lpage><pub-id pub-id-type="pmid">18320317</pub-id></element-citation></ref><ref id="bib0195"><label>17</label><element-citation publication-type="journal" id="sbref0195"><person-group person-group-type="author"><name><surname>Chuah</surname><given-names>H.</given-names></name><name><surname>O&#x02019;Donnell</surname><given-names>D.</given-names></name></person-group><article-title>Angiotensin-converting enzyme inhibitor and visceral angio-oedema</article-title><source>Emerg Med Australas</source><volume>24</volume><year>2012</year><fpage>207</fpage><lpage>208</lpage><pub-id pub-id-type="pmid">22487673</pub-id></element-citation></ref><ref id="bib0200"><label>18</label><element-citation publication-type="journal" id="sbref0200"><person-group person-group-type="author"><name><surname>Haines</surname><given-names>E.C.</given-names></name><name><surname>Wall</surname><given-names>G.C.</given-names></name></person-group><article-title>Possible angiotensin-converting enzyme inhibitor (ACEI)-induced small bowel angioedema</article-title><source>J Pharm Pract</source><volume>24</volume><year>2011</year><fpage>564</fpage><lpage>567</lpage><pub-id pub-id-type="pmid">21676850</pub-id></element-citation></ref><ref id="bib0205"><label>19</label><element-citation publication-type="journal" id="sbref0205"><person-group person-group-type="author"><name><surname>Coelho</surname><given-names>M.L.</given-names></name><name><surname>Amaral</surname><given-names>R.</given-names></name><name><surname>Curvo-Semedo</surname><given-names>L.</given-names></name><name><surname>Caseiro-Alves</surname><given-names>F.</given-names></name></person-group><article-title>Small bowel angioedema induced by angiotensin converting enzyme (ACE) inhibitor: US and CT findings</article-title><source>JBR-BTR</source><volume>97</volume><year>2014</year><fpage>239</fpage><lpage>241</lpage><pub-id pub-id-type="pmid">25603633</pub-id></element-citation></ref><ref id="bib0210"><label>20</label><element-citation publication-type="journal" id="sbref0210"><person-group person-group-type="author"><name><surname>Hachem</surname><given-names>C.Y.</given-names></name><name><surname>Balci</surname><given-names>N.C.</given-names></name><name><surname>Desai</surname><given-names>D.</given-names></name></person-group><article-title>Recurrent nausea: vomiting, and abdominal pain</article-title><source>Gastroenterology</source><volume>138</volume><year>2010</year><fpage>e1</fpage><lpage>e2</lpage></element-citation></ref><ref id="bib0215"><label>21</label><element-citation publication-type="journal" id="sbref0215"><person-group person-group-type="author"><name><surname>Aggarwal</surname><given-names>A.</given-names></name><name><surname>Mehta</surname><given-names>N.</given-names></name><name><surname>Shah</surname><given-names>S.N.</given-names></name></person-group><article-title>Small bowel angioedema associated with angiotensin converting enzyme inhibitor use</article-title><source>J Gen Intern Med</source><volume>26</volume><year>2010</year><fpage>446</fpage><lpage>447</lpage><pub-id pub-id-type="pmid">21104038</pub-id></element-citation></ref><ref id="bib0220"><label>22</label><element-citation publication-type="journal" id="sbref0220"><person-group person-group-type="author"><name><surname>Vallurupalli</surname><given-names>K.</given-names></name><name><surname>Coakley</surname><given-names>K.J.</given-names></name></person-group><article-title>MDCT features of angiotensin-converting enzyme inhibitor-induced visceral angioedema</article-title><source>Am J Roentgenol</source><volume>196</volume><year>2011</year><fpage>w405</fpage><lpage>w411</lpage><pub-id pub-id-type="pmid">21427304</pub-id></element-citation></ref></ref-list></back></article>